Close menu




April 19th, 2021 | 08:10 CEST

Plug Power, Desert Gold, Bayer - Shares with opportunities despite all-time highs?

  • Gold
Photo credits: pixabay.com

Almost all indices are near their all-time highs. No wonder, given the expansive monetary policy and the associated inflation expectations. Commodity prices, in particular, are seeing a sharp rise. Thursday, gold was able to break the resistance area at USD 1,750. Despite this positive environment, however, some stocks are far from their all-time high. We will take a closer look at these today.

time to read: 2 minutes | Author: Armin Schulz
ISIN: US72919P2020 , CA25039N4084 , DE000BAY0017

Table of contents:


    Nick Luksha, President, Prospect Ridge Resources
    "[...] As we look at four or more zones in more detail from the beginning, investors can expect a continuous news flow that will underscore our vision of the Holy Grail project as a giant opportunity. [...]" Nick Luksha, President, Prospect Ridge Resources

    Full interview

     

    Plug Power - Currently still in a downtrend

    It was not that long ago that hydrogen was the trending market. All shares went through the roof. For the past three months, however, the sector has been in a state of gloom. Electromobility has regained the upper hand and so Plug Power's share price fell by over 54% in that time. Last week, the share price fell by 16%. However, if you want to look on the bright side, the stock is still up nearly 450% for the year.

    Morgan Stanley last week put the rating on 'Hold' and adjusted the price target to USD 35. It is evident that Plug Power has been on a growth trajectory for years and meaningful strategic partnerships are being announced regularly. In early April, an alliance with Acciona SA, a large Spanish group, was announced. The goal is to capture 20-30% of the hydrogen market in Spain and Portugal by 2030. As a result, the company would have indirect access to funding from the EU, which plans to support the hydrogen market with subsidies totaling USD 550 billion by 2025.

    Currently, the downward trend is intact. Only above USD 31.70 would the picture brighten significantly.

    Desert Gold - Update on the SMSZ project

    The Desert Gold share has been stuck in a sideways trend between EUR 0.09 and EUR 0.12 since January 11, 2021. That could soon change with the update on the SMSZ project from April 15, 2021, on its exploration wells. The drilling is progressing well, with 5,741 m of 20,000 m completed. 92% of auger drilling has been completed and up to 1,452ppb of gold has been discovered. Gold content was encountered beneath a thin laterite layer in some auger drilling. It is important to note that gold was also hidden under laterite layers in neighboring successful gold mines.

    Results from auger drilling have identified 10 additional target areas, 3 of which are directly related to gold-bearing trend zones. In addition, geophysical data shows areas that are prime targets for gold mineralization.

    With some results still pending, additional target areas may be added for auger drilling. In summary, the area in Mali encompasses high potential, not for nothing are some large gold mines in the immediate vicinity. With rising gold prices and further positive company news, one can assume rising prices. The high of Desert Gold from August 2020 was EUR 0.228.

    Bayer - Difficulties still predominate

    The Monsanto takeover continues to weigh on Bayer's stock to this day. In the last fiscal year alone, provisions and valuation allowances of over EUR 10 billion were made for the lawsuits. Since October 30, 2020, the downward trend has been stopped at around EUR 40.00, with the share price climbing again since then. Since March 11, Bayer stock has moved in a sideways range between EUR 52.01 and EUR 54.78. The 2020 high was above EUR 73.00. On Friday, the share closed at EUR 54.07. From a chart perspective, it has thus broken out of the previously formed wedge.

    Sustained momentum may have been given to the stock by the FDA's announcement on April 15 that it has placed the drug Aliqopa for chronic lymphocytic leukemia on the orphan drug list. In the pharmaceutical field, Bayer has its own approach. They let other companies do research, and if Phase 2 trials are successful, they then take a stake in the companies. After a successful Phase 3 of drug development, the partner can tap into Bayer's existing distribution network.

    Currently, however, the product is not expected to show initial results until 2022 at the earliest. We will probably see soon whether the upper side of the sideways trend at EUR 54.78 will be broken.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Armin Schulz

    Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.

    About the author



    Related comments:

    Commented by Fabian Lorenz on May 12th, 2022 | 11:12 CEST

    BioNTech, BYD and Desert Gold: Shares for the rebound

    • Gold
    • Electromobility
    • Biotechnology

    Is the rebound coming? After the heavy price losses of recent days and weeks, the market seems ripe for a countermovement. However, this would require a little more volume in the market. But then, especially companies that have not disappointed operationally should profit. BioNTech, for example, belongs to this group. The Company has published convincing figures, and analysts see up to 50% price potential. BYD's share price should also pick up speed again. Finally, the rapid shift to electric pureplay seems to be succeeding and HSBC has raised the price target. Gold was not a safe haven in the current correction. But it is worth looking at bombed-out stocks here as well. Desert Gold Ventures is one of them. The explorer has started a new drill program and secured financing.

    Read

    Commented by Armin Schulz on May 6th, 2022 | 10:43 CEST

    Barrick Gold, Edgemont Gold, Rio Tinto - Are gold stocks taking off again?

    • Gold

    With the start of the Ukraine crisis, the gold price skyrocketed, but since March 8, we find ourselves in a consolidation. The 200-day line is currently holding, and it could go up again from here. But let's look at the reasons for the weakness in the gold price. On the one hand, there is the strong dollar, which naturally puts pressure on the gold price, and on the other hand, bond yields in the US are climbing again. After the FED announced on May 4 that it would not raise interest rates by more than 0.5 percentage points, which was originally feared, the gold price jumped again. Demand for physical gold remains high. We look at three companies in the gold sector.

    Read

    Commented by Stefan Feulner on May 5th, 2022 | 10:46 CEST

    Rheinmetall, Triumph Gold, K+S - Hype or sustainable?

    • Gold
    • fertilizer
    • Defense

    Already during the Corona pandemic, clear winners and losers could be identified. Vaccine manufacturers multiplied, and companies related to online trading also performed better than the market. In the current Ukraine crisis, however, the signs are changing. Suddenly, defense stocks, which were frowned upon a short time ago, are all the rage. Fertilizer companies, benefiting from the sanctions and the resulting supply shortages, are also gaining favor with investors. But how sustainable are the current increases? Gold mining stocks are also doing very well, but in contrast to Rheinmetall, Hensoldt & Co., they are performing much weaker.

    Read